Correlation Between MMP9 Promoter Methylation and Transient Ischemic Attack/Mild Ischemic Stroke with Early Cognitive Impairment

References

• Suda S, Nishimura T, Ishiwata A, et al. Early cognitive impairment after minor stroke: associated factors and functional outcome. J Stroke Cerebrovasc Dis. 2020;29(5):104749. doi:10.1016/j.jstrokecerebrovasdis.2020.104749
   PubMed Web of Science ®Google Scholar
• Pendlebury ST, Wadling S, Silver LE, Mehta Z, Rothwell PM. Transient cognitive impairment in TIA and minor stroke. Stroke. 2011;42(11):3116–3121. doi:10.1161/STROKEAHA.111.621490
   PubMed Web of Science ®Google Scholar
• Blackburn DJ, Bafadhel L, Randall M, Harkness KA. Cognitive screening in the acute stroke setting. Age Ageing. 2013;42(1):113–116. doi:10.1093/ageing/afs116
   PubMed Web of Science ®Google Scholar
• Godefroy O, Fickl A, Roussel M, et al. Is the Montreal cognitive assessment superior to the mini-mental state examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation. Stroke. 2011;42(6):1712–1716. doi:10.1161/STROKEAHA.110.606277
   PubMed Web of Science ®Google Scholar
• Qin X, Li J, Wu T, et al. Overall and sex-specific associations between methylation of the ABCG1 and APOE genes and ischemic stroke or other atherosclerosis-related traits in a sibling study of Chinese population. Clin Epigenetics. 2019;11(1):189. doi:10.1186/s13148-019-0784-0
   PubMed Web of Science ®Google Scholar
• Lin HF, Hsi E, Huang LC, Liao YC, Juo SH, Lin RT. Methylation in the matrix metalloproteinase-2 gene is associated with cerebral ischemic stroke. J Investig Med. 2017;65(4):794–799. doi:10.1136/jim-2016-000277
   PubMed Web of Science ®Google Scholar
• Wei Y, Sun Z, Wang Y, et al. Methylation in the TP53 promoter is associated with ischemic stroke. Mol Med Rep. 2019;20(2):1404–1410. doi:10.3892/mmr.2019.10348
   PubMed Web of Science ®Google Scholar
• Lin RT, Hsi E, Lin HF, Liao YC, Wang YS, Juo SH. LINE-1 methylation is associated with an increased risk of ischemic stroke in men. Curr Neurovasc Res. 2014;11(1):4–9. doi:10.2174/1567202610666131202145530
   PubMed Web of Science ®Google Scholar
• Zhou S, Zhang Y, Wang L, et al. CDKN2B methylation is associated with carotid artery calcification in ischemic stroke patients. J Transl Med. 2016;14(1):333. doi:10.1186/s12967-016-1093-4
   PubMedGoogle Scholar
• Zhou S, Cai B, Zhang Z, et al. CDKN2B Methylation and Aortic Arch Calcification in Patients with Ischemic Stroke. J Atheroscler Thromb. 2017;24(6):609–620. doi:10.5551/jat.36897
   PubMed Web of Science ®Google Scholar
• Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005;57(2):173–185. doi:10.1124/pr.57.2.4
   PubMed Web of Science ®Google Scholar
• Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis. 2010;37(1):13–25. doi:10.1016/j.nbd.2009.07.030
   PubMed Web of Science ®Google Scholar
• Jiang X, Andjelkovic AV, Zhu L, et al. Blood-brain barrier dysfunction and recovery after ischemic stroke. Prog Neurobiol. 2018;163–164:144–171. doi:10.1016/j.pneurobio.2017.10.001
   PubMed Web of Science ®Google Scholar
• Huang J, Upadhyay UM, Tamargo RJ. Inflammation in stroke and focal cerebral ischemia. Surg Neurol. 2006;66(3):232–245. doi:10.1016/j.surneu.2005.12.028
   PubMedGoogle Scholar
• Goulay R, Mena Romo L, Hol EM, Dijkhuizen RM. From stroke to dementia: a comprehensive review exposing tight interactions between stroke and amyloid-β formation. Transl Stroke Res. 2020;11(4):601–614. doi:10.1007/s12975-019-00755-2
   PubMed Web of Science ®Google Scholar
• Hawkes CA, Jayakody N, Johnston DA, Bechmann I, Carare RO. Failure of perivascular drainage of β-amyloid in cerebral amyloid angiopathy. Brain Pathol. 2014;24(4):396–403. doi:10.1111/bpa.12159
   PubMed Web of Science ®Google Scholar
• Tarasoff-Conway JM, Carare RO, Osorio RS, et al. Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol. 2015;11(8):457–470. doi:10.1038/nrneurol.2015.119
   PubMed Web of Science ®Google Scholar
• Zhong C, Yang J, Xu T, et al. Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke. Neurology. 2017;89(8):805–812. doi:10.1212/WNL.0000000000004257
   PubMed Web of Science ®Google Scholar
• Rodríguez-Yáñez M, Castellanos M, Blanco M, et al. New-onset hypertension and inflammatory response/poor outcome in acute ischemic stroke. Neurology. 2006;67(11):1973–1978. doi:10.1212/01.wnl.0000247064.53130.91
   PubMed Web of Science ®Google Scholar
• Cui J, Chen S, Zhang C, et al. Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia. Mol Neurodegener. 2012;7:21. doi:10.1186/1750-1326-7-21
   PubMed Web of Science ®Google Scholar
• Yang Y, Thompson JF, Taheri S, et al. Early inhibition of MMP activity in ischemic rat brain promotes expression of tight junction proteins and angiogenesis during recovery. J Cereb Blood Flow Metab. 2013;33(7):1104–1114. doi:10.1038/jcbfm.2013.56
   PubMed Web of Science ®Google Scholar
• Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke. 1998;29(5):1020–1030. doi:10.1161/01.str.29.5.1020
   PubMed Web of Science ®Google Scholar
• Turner RJ, Sharp FR. Implications of MMP9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke. Front Cell Neurosci. 2016;10:56. doi:10.3389/fncel.2016.00056
   PubMed Web of Science ®Google Scholar
• Tian JZ, Xie HG, Qin B, et al. Screening and diagnostic framework of vascular dementia in Chinese population. Zhonghua Nei Ke Za Zhi. 2019;58(1):10–16. doi:10.3760/cma.j.issn.0578-1426.2019.01.003
   PubMedGoogle Scholar
• Hao L, Xing Y, Li X, et al. Risk Factors and neuropsychological assessments of subjective cognitive decline (plus) in Chinese memory clinic. Front Neurosci. 2019;13:846. doi:10.3389/fnins.2019.00846
   PubMed Web of Science ®Google Scholar
• Ma J, Zhang Y, Guo Q. Comparison of vascular cognitive impairment--no dementia by multiple classification methods. Int J Neurosci. 2015;125(11):823–830. doi:10.3109/00207454.2014.972504
   PubMed Web of Science ®Google Scholar
• Xu Y, Chen K, Zhao Q, Li F, Guo Q. Short-term delayed recall of auditory verbal learning test provides equivalent value to long-term delayed recall in predicting MCI clinical outcomes: a longitudinal follow-up study. Appl Neuropsychol Adult. 2020;27(1):73–81. doi:10.1080/23279095.2018.1481067
   PubMed Web of Science ®Google Scholar
• Llinàs-Reglà J, Vilalta-Franch J, López-Pousa S, Calvó-Perxas L, Torrents Rodas D, Garre-Olmo J. The trail making test. Assessment. 2017;24(2):183–196. doi:10.1177/1073191115602552
   PubMed Web of Science ®Google Scholar
• Sánchez-Cubillo I, Periáñez JA, Adrover-Roig D, et al. Construct validity of the Trail Making Test: role of task-switching, working memory, inhibition/interference control, and visuomotor abilities. J Int Neuropsychol Soc. 2009;15(3):438–450. doi:10.1017/S1355617709090626
   PubMed Web of Science ®Google Scholar
• Wei M, Shi J, Li T, et al. Diagnostic accuracy of the Chinese version of the trail-making test for screening cognitive impairment. J Am Geriatr Soc. 2018;66(1):92–99. doi:10.1111/jgs.15135
   PubMed Web of Science ®Google Scholar
• Gorelick PB, Counts SE, Nyenhuis D. Vascular cognitive impairment and dementia. Biochim Biophys Acta. 2016;1862(5):860–868. doi:10.1016/j.bbadis.2015.12.015
   PubMed Web of Science ®Google Scholar
• Ashktorab H, Daremipouran M, Goel A, et al. DNA methylome profiling identifies novel methylated genes in African American patients with colorectal neoplasia. Epigenetics. 2014;9(4):503–512. doi:10.4161/epi.27644
   PubMed Web of Science ®Google Scholar
• Wilmot B, Fry R, Smeester L, Musser ED, Mill J, Nigg JT. Methylomic analysis of salivary DNA in childhood ADHD identifies altered DNA methylation in VIPR2. J Child Psychol Psychiatry. 2016;57(2):152–160. doi:10.1111/jcpp.12457
   PubMed Web of Science ®Google Scholar
• Masser DR, Berg AS, Freeman WM. Focused, high accuracy 5-methylcytosine quantitation with base resolution by benchtop next-generation sequencing. Epigenetics Chromatin. 2013;6(1):33. doi:10.1186/1756-8935-6-33
   PubMedGoogle Scholar
• Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab. 2007;27(4):697–709. doi:10.1038/sj.jcbfm.9600375
   PubMed Web of Science ®Google Scholar
• Planas AM, Solé S, Justicia C. Expression and activation of matrix metalloproteinase-2 and −9 in rat brain after transient focal cerebral ischemia. Neurobiol Dis. 2001;8(5):834–846. doi:10.1006/nbdi.2001.0435
   PubMed Web of Science ®Google Scholar
• Stamatovic SM, Johnson AM, Keep RF, Andjelkovic AV. Junctional proteins of the blood-brain barrier: new insights into function and dysfunction. Tissue Barriers. 2016;4(1):e1154641. doi:10.1080/21688370.2016.1154641
   PubMed Web of Science ®Google Scholar
• Lenglet S, Montecucco F, Mach F, Schaller K, Gasche Y, Copin JC. Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke. Thromb Haemost. 2014;112(2):363–378. doi:10.1160/TH14-01-0007
   PubMed Web of Science ®Google Scholar
• Zhong C, Bu X, Xu T, et al. Serum matrix metalloproteinase-9 and cognitive impairment after acute ischemic stroke. J Am Heart Assoc. 2018;7(1):e007776. doi:10.1161/JAHA.117.007776
   PubMed Web of Science ®Google Scholar
• Bruno MA, Mufson EJ, Wuu J, Cuello AC. Increased matrix metalloproteinase 9 activity in mild cognitive impairment. J Neuropathol Exp Neurol. 2009;68(12):1309–1318. doi:10.1097/NEN.0b013e3181c22569
   PubMed Web of Science ®Google Scholar
• Adair JC, Charlie J, Dencoff JE, et al. Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease. Stroke. 2004;35(6):e159–e162. doi:10.1161/01.STR.0000127420.10990.76
   PubMed Web of Science ®Google Scholar
• Candelario-Jalil E, Thompson J, Taheri S, et al. Matrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairment. Stroke. 2011;42(5):1345–1350. doi:10.1161/STROKEAHA.110.600825
   PubMed Web of Science ®Google Scholar
• Hoshino T, Sissani L, Labreuche J, et al. Prevalence of systemic atherosclerosis burdens and overlapping stroke etiologies and their associations with long-term vascular prognosis in stroke with intracranial atherosclerotic disease. JAMA Neurol. 2018;75(2):203–211. doi:10.1001/jamaneurol.2017.3960
   PubMed Web of Science ®Google Scholar
• Chen T, Chen X, Zhang S, et al. The genome sequence archive family: toward explosive data growth and diverse data types. Genomics Proteomics Bioinformatics. 2021;19(4):578–583. PMID=34400360. doi:10.1016/j.gpb.2021.08.001
   PubMed Web of Science ®Google Scholar
• Members CN. Database resources of the national genomics data center, China national center for bioinformation in 2022. Nucleic Acids Res. 2022;50(D1):D27–D38. PMID=34718731. doi:10.1093/nar/gkab951
   PubMed Web of Science ®Google Scholar